thanks gsw and leo i just wanted to get some opinions as i want to cover all angles.
to me an excellent update which gsw, scilly and others have covered very well. The one thing i do want to add is that im impressed that sbn had two seperate reviews completed by third parties re the market and fda. To me this is best practice in everyway. We can confirm and realign if necessary our target markets in the united states and other countries (plus confirm what a bonus our jv with bioscreens is going to be)
And as far as the fda is concerned highlight what we need to do and im guessing where we stuffed up last time. Very Very good business practice.
not to mention the substantial unit sales and revenue increase.
SBN Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
